Priscila Calle
Barcelona, CT 08036, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
PBMC therapy reduces cell death and tissue fibrosis after acute kidney injury by modulating the pattern of monocyte/macrophage survival in tissue.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 12, 2024
The phagocytosis dysfunction in lupus nephritis is related to monocyte/macrophage CPT1a.
Journal: Immunology letters
Published: June 15, 2023
NGAL release from peripheral blood mononuclear cells protects against acute kidney injury and prevents AKI induced fibrosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 13, 2022
Macrophage Phenotype and Fibrosis in Diabetic Nephropathy.
Journal: International journal of molecular sciences
Published: February 26, 2020
CPT1a downregulation protects against cholesterol-induced fibrosis in tubular epithelial cells by downregulating TGFβ-1 and inflammasome.
Journal: Biochemical and biophysical research communications
Published: July 22, 2019
CPT1a gene expression reverses the inflammatory and anti-phagocytic effect of 7-ketocholesterol in RAW264.7 macrophages.
Journal: Lipids in health and disease
Published: May 29, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026